Petra Fettes

Title: Petra Fettes: Innovator in Ophthalmic Treatments

Introduction

Petra Fettes is a distinguished inventor based in Munich, Germany. She has made significant contributions to the field of ophthalmology through her innovative research and development of therapeutic solutions. Her work focuses on addressing critical issues related to ophthalmic diseases.

Latest Patents

Petra Fettes holds a patent for a TGF-beta oligonucleotide designed for use in the treatment of ophthalmic diseases. The invention is directed to an oligonucleotide comprising a nucleic acid sequence of SEQ ID No. 1 or parts thereof. This oligonucleotide features modifications at the 3'-end and/or 5'-end, which enhance its efficacy in reducing or inhibiting scarring, fibrotic closure of the trabeculectomy canal, and epithelial-to-mesenchymal transition of the trabecular meshwork. Additionally, it provides protective activity for the optic nerve, including the optic nerve head. The patent also includes a pharmaceutical composition that comprises this oligonucleotide and a pharmaceutically acceptable carrier.

Career Highlights

Petra Fettes is currently associated with Isarna Therapeutics GmbH, where she continues to advance her research in ophthalmic treatments. Her innovative approach and dedication to her work have positioned her as a key figure in her field.

Collaborations

Throughout her career, Petra has collaborated with notable professionals, including Eugen Leo and Michel Janicot. These collaborations have further enriched her research and contributed to the development of effective therapeutic solutions.

Conclusion

Petra Fettes is a remarkable inventor whose work in ophthalmic treatments has the potential to significantly impact patient care. Her innovative patent and ongoing research efforts exemplify her commitment to advancing medical science.